{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:28:12Z","timestamp":1788931692275,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180991"],"award-info":[{"award-number":["BK20180991"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jocn.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T06:28:45Z","timestamp":1651040925000},"page":"192-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease"],"prefix":"10.1016","volume":"100","author":[{"given":"Han","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Khuram Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2022.04.015_b0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2022.04.015_b0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tins.2019.01.003","article-title":"Vitamin D in Synaptic Plasticity, Cognitive Function, and Neuropsychiatric Illness","volume":"42","author":"Mayne","year":"2019","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.015_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","article-title":"Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats","volume":"904","author":"Wang","year":"2001","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.jocn.2022.04.015_b0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2004.07.008","article-title":"Behavioural characterization of vitamin D receptor knockout mice","volume":"157","author":"Burne","year":"2005","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11064-006-9048-4","article-title":"Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine","volume":"31","author":"Smith","year":"2006","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.015_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-121735","article-title":"1\u03b1,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-\u03b2 Phagocytosis and Inflammation in Alzheimer's Disease Patients","volume":"34","author":"Mizwicki","year":"2013","journal-title":"JAD"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/ane.13141","article-title":"Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson's disease symptoms","volume":"140","author":"Zhang","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2022.04.015_b0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/nu8030142","article-title":"Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease","volume":"8","author":"Wang","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mds.26117","article-title":"Vitamin D from different sources is inversely associated with Parkinson disease: VITAMIN D2, D3, AND PARKINSON'S DISEASE","volume":"30","author":"Wang","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JPD-171122","article-title":"The Role of Vitamin D in Disease Progression in Early Parkinson's Disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"10.1016\/j.jocn.2022.04.015_b0060","first-page":"1295","article-title":"Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults","volume":"72","author":"Miller","year":"2015","journal-title":"JAMANeurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.015_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ggi.13821","article-title":"Effect of vitamin D on cognitive function and white matter hyperintensity in patients with mild Alzheimer's disease","volume":"20","author":"Shih","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jocn.2022.04.015_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ypmed.2018.05.010","article-title":"The association between serum vitamin d level and cognitive function in older adults: Cooper Center Longitudinal Study","volume":"113","author":"Pavlovic","year":"2018","journal-title":"Prev Med"},{"issue":"7","key":"10.1016\/j.jocn.2022.04.015_b0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ggi.12826","article-title":"Association of metabolic syndrome and 25-hydroxyvitamin D with cognitive impairment among elderly Koreans","volume":"17","author":"Lee","year":"2017","journal-title":"Geriatr Gerontol Int"},{"issue":"11","key":"10.1016\/j.jocn.2022.04.015_b0080","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1080\/13607863.2020.1839860","article-title":"Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians","volume":"25","author":"Santangelo","year":"2021","journal-title":"Aging Ment Health"},{"issue":"12","key":"10.1016\/j.jocn.2022.04.015_b0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease: MDS-PD Clinical Diagnostic Criteria","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.jocn.2022.04.015_b0090","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jocn.2022.04.015_b0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines : PD-MCI Diagnostic Criteria","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jocn.2022.04.015_b0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson\u2018s disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.jocn.2022.04.015_b0105","first-page":"1","article-title":"Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease","author":"Barichella","year":"2020","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.jocn.2022.04.015_b0110","article-title":"1,25(OH)(2)D(3) Alleviates A\u03b2(25-35)-Induced Tau Hyperphosphorylation, Excessive Reactive Oxygen Species, and Apoptosis Through Interplay with Glial Cell Line-Derived Neurotrophic Factor Signaling in SH-SY5Y Cells","volume":"21","author":"Lin","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jocn.2022.04.015_b0115","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/ijms18122764","article-title":"Vitamin D and Its Analogues Decrease Amyloid-\u03b2 (A\u03b2) Formation and Increase A\u03b2-Degradation","volume":"18","author":"Grimm","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jocn.2022.04.015_b0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1567205015666171227154636","article-title":"Vitamin D Increases A\u03b2140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients","volume":"15","author":"SanMart\u00edn","year":"2018","journal-title":"CAR"},{"key":"10.1016\/j.jocn.2022.04.015_b0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2018.07.009","article-title":"Vitamin D inhibits palmitate-induced macrophage pro-inflammatory cytokine production by targeting the MAPK pathway","volume":"202","author":"Li","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jocn.2022.04.015_b0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2016.01.015","article-title":"Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism","volume":"292","author":"Boontanrart","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2022.04.015_b0135","doi-asserted-by":"crossref","first-page":"117703","DOI":"10.1016\/j.lfs.2020.117703","article-title":"Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress","volume":"253","author":"Mokhtari-Zaer","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jocn.2022.04.015_b0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hbm.24380","article-title":"Vitamin D deficiency is associated with reduced hippocampal volume and disrupted structural connectivity in patients with mild cognitive impairment","volume":"40","author":"Al-Amin","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.015_b0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1179\/1476830513Y.0000000080","article-title":"Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease","volume":"17","author":"Taghizadeh","year":"2014","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.jocn.2022.04.015_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.04.020","article-title":"Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis","volume":"65","author":"Saredakis","year":"2019","journal-title":"Parkinsonism Related Disord"},{"key":"10.1016\/j.jocn.2022.04.015_b0155","article-title":"Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions","volume":"11","author":"Sun","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"10.1016\/j.jocn.2022.04.015_b0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fneur.2020.00454","article-title":"A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms","volume":"11","author":"Fullard","year":"2020","journal-title":"Front Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:32:05Z","timestamp":1760823125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S0967586822001734"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.04.015","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}